W. James Deardorff

1.1k total citations
31 papers, 670 citations indexed

About

W. James Deardorff is a scholar working on Psychiatry and Mental health, Geriatrics and Gerontology and Pharmacology. According to data from OpenAlex, W. James Deardorff has authored 31 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 13 papers in Geriatrics and Gerontology and 6 papers in Pharmacology. Recurrent topics in W. James Deardorff's work include Dementia and Cognitive Impairment Research (11 papers), Pharmaceutical Practices and Patient Outcomes (8 papers) and Frailty in Older Adults (5 papers). W. James Deardorff is often cited by papers focused on Dementia and Cognitive Impairment Research (11 papers), Pharmaceutical Practices and Patient Outcomes (8 papers) and Frailty in Older Adults (5 papers). W. James Deardorff collaborates with scholars based in United States, Bulgaria and Canada. W. James Deardorff's co-authors include George T. Grossberg, Eliahu S. Feen, Sei J. Lee, Brian T. Nguyen, Irena Cenzer, W. John Boscardin, Richard Sloane, Carl F. Pieper, Susan N. Hastings and Courtney H. Van Houtven and has published in prestigious journals such as JAMA, Biochemistry and Journal of the American Geriatrics Society.

In The Last Decade

W. James Deardorff

27 papers receiving 655 citations

Peers

Countries citing papers authored by W. James Deardorff

Since Specialization

Citations

This map shows the geographic impact of W. James Deardorff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. James Deardorff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. James Deardorff more than expected).

Fields of papers citing papers by W. James Deardorff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. James Deardorff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. James Deardorff. The network helps show where W. James Deardorff may publish in the future.

Co-authorship network of co-authors of W. James Deardorff

This figure shows the co-authorship network connecting the top 25 collaborators of W. James Deardorff. A scholar is included among the top collaborators of W. James Deardorff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. James Deardorff. W. James Deardorff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Six‐Month Prognostic Tool for Community‐Dwelling People With Dementia 2025 ·Journal of the American Geriatrics Society ·Krista L. Harrison, Sun Young Jeon, W. James Deardorff, Alexandra K. Lee, Lauren J. Hunt, Claire K. Ankuda, Melissa D. Aldridge, Kenneth E. Covinsky, Irena Cenzer, W. John Boscardin, Sei J. Lee, Alexander K. Smith	0
2	External Validation of the Walter Index for Posthospitalization Mortality Prediction in Older Adults 2025 ·JAMA Network Open ·Thiago Junqueira Avelino‐Silva, Sei J. Lee, Kenneth E. Covinsky, Louise Aronson, W. James Deardorff, W. John Boscardin, Flávia Campora, Cláudia Szlejf, Cláudia Kimie Suemoto, Alexander K. Smith	1
3	A Multi-Outcome Prognostic Model for Community-Dwelling Older Adults Admitted to Skilled Nursing Facilities for Post-Acute Care 2025 ·Journal of the American Medical Directors Association ·W. James Deardorff, Siqi Gan, Bocheng Jing, W. John Boscardin, Alexander K. Smith, Sei J. Lee	0
4	“Nobody Can Be Equipped for This”: Advice From New Residents of Long‐Term Care Facilities 2025 ·Journal of the American Geriatrics Society ·Kenneth Lam, James D. Harrison, (unknown), W. James Deardorff, Rebecca L. Sudore, Kenneth E. Covinsky, Daniel D. Matlock, Daniel Dohan	1
5	Which older adults are at highest risk of prescribing cascades? A national study of the gabapentinoid–loop diuretic cascade 2024 ·Journal of the American Geriatrics Society ·Matthew E. Growdon, Bocheng Jing, (unknown), W. James Deardorff, W. John Boscardin, Amy L. Byers, Kenneth S. Boockvar, Michael A. Steinman	4
6	Deprescribing of Antihypertensive Medications and Cognitive Function in Nursing Home Residents 2024 ·JAMA Internal Medicine ·Bocheng Jing, Xiaojuan Liu, Laura A. Graham, Chintan Dave, Yongmei Li, Kathy Fung, Christine K. Liu, Hoda S. Abdel Magid, Matthew E. Growdon, W. James Deardorff, W. John Boscardin, Sei J. Lee, Michael A. Steinman, Michelle C. Odden	9
7	Medication misuse and overuse in community‐dwelling persons with dementia 2023 ·Journal of the American Geriatrics Society ·W. James Deardorff, Bocheng Jing, Matthew E. Growdon, Kristine Yaffe, W. John Boscardin, Kenneth S. Boockvar, Michael A. Steinman	5
8	Frequency of Screening for Colorectal Cancer by Predicted Life Expectancy Among Adults 76-85 Years 2023 ·JAMA ·W. James Deardorff, (unknown), Bocheng Jing, Sun Young Jeon, W. John Boscardin, Kathy Fung, Sei J. Lee	1
9	Development and External Validation of Models to Predict Need for Nursing Home Level of Care in Community-Dwelling Older Adults With Dementia 2023 ·JAMA Internal Medicine ·W. James Deardorff, Sun Young Jeon, Deborah E. Barnes, W. John Boscardin, Kenneth M. Langa, Kenneth E. Covinsky, Susan L. Mitchell, Sei J. Lee, Alexander K. Smith	5
10	UNNECESSARY AND HARMFUL MEDICATION USE IN COMMUNITY DWELLING PERSONS WITH DEMENTIA 2022 ·Innovation in Aging ·W. James Deardorff, Bocheng Jing, Matthew E. Growdon, Kristine Yaffe, Kenneth S. Boockvar, Michael A. Steinman	1
11	Do functional status and Medicare claims data improve the predictive accuracy of an electronic health record mortality index? Findings from a national Veterans Affairs cohort 2022 ·BMC Geriatrics ·W. James Deardorff, Bocheng Jing, Sun Young Jeon, W. John Boscardin, Alexandra K. Lee, Kathy Fung, Sei J. Lee	1
12	Regulation of Iron Homeostasis through Parkin-Mediated Lactoferrin Ubiquitylation 2020 ·Biochemistry ·Ankur A. Gholkar, Stefan Schmollinger, (unknown), Yu‐Chen Lo, Whitaker Cohn, Joseph Capri, (unknown), W. James Deardorff, (unknown), Mai Abdusamad, Julian P. Whitelegge, Jorge Z. Torres	6
13	Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia 2019 ·Handbook of clinical neurology ·W. James Deardorff, George T. Grossberg	71
14	Association of Sensory and Cognitive Impairment With Healthcare Utilization and Cost in Older Adults 2019 ·Journal of the American Geriatrics Society ·W. James Deardorff, (unknown), Richard Sloane, Courtney H. Van Houtven, Carl F. Pieper, Susan N. Hastings, Harvey Jay Cohen, Heather E. Whitson	41
15	Efficacy of rivastigmine tartrate, transdermal system, in Alzheimer’s disease 2016 ·Expert Opinion on Pharmacotherapy ·(unknown), W. James Deardorff, George T. Grossberg	6
16	A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer’s disease 2016 ·Drug Design Development and Therapy ·W. James Deardorff, George T. Grossberg	88
17	The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer’s Disease 2015 ·Drugs & Aging ·W. James Deardorff, Eliahu S. Feen, George T. Grossberg	102
18	The Pharmacology and Clinical Use of the Antidepressants Vilazodone, Levomilnacipran, and Vortioxetine for Depression in the Elderly 2015 ·Current Geriatrics Reports ·W. James Deardorff, George T. Grossberg	2
19	A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine 2014 ·Expert Opinion on Pharmacotherapy ·W. James Deardorff, George T. Grossberg	37
20	Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication 2014 ·Expert Review of Neurotherapeutics ·W. James Deardorff, (unknown), George T. Grossberg	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact